药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cyclopentolate
Baricitinib
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Baricitinib.
Cyclopentolate
Cabotegravir
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Cabotegravir.
Cyclopentolate
Lenvatinib
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Lenvatinib.
Cyclopentolate
Cefaloridine
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Cefaloridine.
Cyclopentolate
Dolutegravir
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Dolutegravir.
Cyclopentolate
Dabrafenib
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Dabrafenib.
Cyclopentolate
Teriflunomide
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Teriflunomide.
Cyclopentolate
Ataluren
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Ataluren.
Cyclopentolate
Caprylic acid
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Caprylic acid.
Cyclopentolate
Taurocholic acid
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Taurocholic acid.
Cyclopentolate
Benzoic acid
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Benzoic acid.
Cyclopentolate
Glutaric Acid
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Glutaric Acid.
Cyclopentolate
Cholic Acid
The excretion of Cyclic adenosine monophosphate can be decreased when combined with Cholic Acid.
Apraclonidine
Reviparin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Reviparin.
Apraclonidine
Edetic acid
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Edetic acid.
Apraclonidine
Troxerutin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Troxerutin.
Apraclonidine
Dabigatran etexilate
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Dabigatran etexilate.
Apraclonidine
Semuloparin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Semuloparin.
Apraclonidine
Dabigatran
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Dabigatran.
Apraclonidine
Edetate calcium disodium anhydrous
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Edetate calcium disodium anhydrous.